We are live on ! Find out more
MAIA icon

MAIA Biotechnology
MAIA

20 hedge funds and large institutions have $3.95M invested in MAIA Biotechnology in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 0 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more capital invested

Capital invested by funds: $2.26M → $3.95M (+$1.69M)

2.54% more ownership

Funds ownership: 4.99% → 7.54% (+2.5%)

0% more funds holding

Funds holding: 20 → 20 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
20
Holders Change
–
Holders Change %
0%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
10
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CWM
Centric Wealth Management
Illinois
+$904K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$878K
3
Jane Street
Jane Street
New York
+$51.5K
4
State Street
State Street
Massachusetts
+$39.9K
5
BlackRock
BlackRock
New York
+$34.3K

Top Sellers

Rank Fund Capital Flow
1
HFF
Halter Ferguson Financial
Indiana
-$363K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$84.3K
3
NW
Naviter Wealth
Arkansas
-$16.2K
4
BWM
Bernard Wealth Management
Michigan
-$765
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$2.05M +$878K +490,513 +75%
CWM
2
Centric Wealth Management
Illinois
$872K +$904K +505,150 +740%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$400K +$13.9K +7,746 +4%
BlackRock
4
BlackRock
New York
$186K +$34.3K +19,182 +23%
State Street
5
State Street
Massachusetts
$136K +$39.9K +22,300 +42%
Northern Trust
6
Northern Trust
Illinois
$70.3K – – –
BCM
7
Bridgeway Capital Management
Texas
$64.8K – – –
Jane Street
8
Jane Street
New York
$51.8K +$51.5K +28,783 New
Marshall Wace
9
Marshall Wace
United Kingdom
$29.1K +$28.9K +16,165 New
CAG
10
Centerpoint Advisory Group
Kansas
$28.3K +$28.2K +15,730 New
Wealth Enhancement Advisory Services
11
Wealth Enhancement Advisory Services
Minnesota
$27.4K – – –
Osaic Holdings
12
Osaic Holdings
Arizona
$15K +$1.58K +884 +12%
Morgan Stanley
13
Morgan Stanley
New York
$9.17K – – –
UBS Group
14
UBS Group
Switzerland
$3.82K +$3.26K +1,820 +607%
TRCT
15
Tower Research Capital (TRC)
New York
$3.33K +$2.88K +1,608 +673%
MCM
16
MAI Capital Management
Ohio
$1.22K – – –
Bank of America
17
Bank of America
North Carolina
$416 +$93 +52 +29%
Jones Financial Companies
18
Jones Financial Companies
Missouri
$404 – – –
Raymond James Financial
19
Raymond James Financial
Florida
$180 +$179 +100 New
JP Morgan Chase
20
JP Morgan Chase
New York
$90 +$14 +8 +19%
HFF
21
Halter Ferguson Financial
Indiana
– -$363K -237,356 Closed
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
– -$84.3K -55,100 Closed
NW
23
Naviter Wealth
Arkansas
– -$16.2K -10,000 Closed
BWM
24
Bernard Wealth Management
Michigan
– -$765 -500 Closed

MAIA Hedge Fund Activity: Q2 2025 in Review

20 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in MAIA Biotechnology (MAIA) for Q2 2025, worth a combined $3.95M — up 75% from $2.26M a quarter earlier.

Fund positioning in MAIA was balanced in Q2 2025: 4 funds opened new positions, 4 closed out, 10 added to existing stakes and 0 trimmed.

The largest buyer was Centric Wealth Management, adding an estimated $904K. The largest seller was Halter Ferguson Financial, exiting entirely with an estimated $363K sold.

  • 20 institutional investors held MAIA Biotechnology (MAIA) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $3.95M of MAIA Biotechnology stock for Q2 2025, up 75% quarter-over-quarter.
  • 4 funds opened new MAIA Biotechnology positions in Q2 2025 and 4 closed out, a net change of 0 holders.
  • The largest MAIA Biotechnology buyer in Q2 2025 was Centric Wealth Management, an estimated $904K added.
  • The largest MAIA Biotechnology seller in Q2 2025 was Halter Ferguson Financial, an estimated $363K sold.

Based on aggregated 13F filings for Q2 2025.